
Jiahe Tian
Articles
-
Dec 5, 2024 |
mdpi.com | Jiahe Tian |Shida Pan |Yilin Wang |Yingying Yu
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
-
Oct 17, 2024 |
biorxiv.org | Jiahe Tian |Sophie Ross |Benjamin Ciener |Sandra Leskinen
AbstractHuman brain tissue studies have historically used a range of metrics to assess RNA quality. However, few large-scale cross-comparisons of pre-sequencing quality metrics with RNA-seq quality have been published.
-
May 21, 2024 |
mdpi.com | Jiahe Tian |Yingying Yu |Yaoru Song |Shida Pan
All articles published by MDPI are made immediately available worldwide under an open access license. No specialpermission is required to reuse all or part of the article published by MDPI, including figures and tables. Forarticles published under an open access Creative Common CC BY license, any part of the article may be reused withoutpermission provided that the original article is clearly cited. For more information, please refer tohttps://www.mdpi.com/openaccess.
-
Aug 15, 2023 |
mdpi.com | Wenya Yu |Zhichao Guo |Panpan Li |Jiahe Tian
1. IntroductionThe global coronavirus disease 2019 (COVID-19) pandemic has caused significant social, economic, and medical threats to all people. By 22 December 2022, there were 650,879,143 confirmed cases and 6,651,415 deaths globally [1]. To mitigate the transmission of COVID-19, lockdown regulations were instituted in most countries [2,3], including China. The national lockdown in China was implemented only during the first outbreak peak in Wuhan, in December 2019.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →